Immunohistochemical examination of mucinous cystadenoma of the testis

Pathology International

Volumn 54, Issue 5, 2004, Pages 355-359

  Naito, Shinji ^a,c   Yamazumi, Kazuyuki ^a,b   Yakata, Yuichi ^a,b   Shono, Takefumi ^a   Hakariya, Hironobu ^a   Nakayama, Toshiyuki ^b   Nakashima, Masahiro ^b   Sekine, Ichiro ^b  

^a Ureshino Medical Center   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUJITSU LABORATORIES LTD   (Japan)

Author keywords

CK20; CK7; MUC2; MUC5AC; Mucinous cystadenoma

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CALRETININ; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CHROMOGRANIN A; CYCLIN D1; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MUCIN 2; MUCIN 5AC; MUCIN 6; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; ANAMNESIS; ANTIGEN DETECTION; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL INVASION; CELL TYPE; CLINICAL EXAMINATION; CLINICAL FEATURE; CYSTADENOMA; EPIDIDYMIS; EPITHELIUM CELL; GENERAL CONDITION IMPROVEMENT; GERM CELL; GOBLET CELL; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; ORCHIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETE TESTIS; TESTIS TUMOR; TUMOR CELL;

CYSTADENOCARCINOMA, MUCINOUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ORCHIECTOMY; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 2642545715     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01631.x     Document Type: Article

References (21)

1. Nokubi M, Kawai T, Mitsu S, Ishikawa S, Morinaga S. Mucinous cystadenoma of the testis. Pathol Int 2002; 52: 648-52.
2. Ulbright TM, Amin MB, Young RH. Miscellaneous primary tumors of the testis, adnexa, and spermatic cord hematopoietic tumors secondary tumors. In: Rosai J, Sobin LH, eds. Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum - Atlas of Tumor Pathology. Third Series, Fascicle 25. Washington DC: Armed Forces Institute of Pathology, 1999; 235-90.
3. McClure RF, Keeney GL, Sebo TJ, Cheville JC. Serous borderline tumors of the paratestis. A report of seven cases. Am J Sur Pathol 2001; 25: 373-8.
4. Young RH, Scully RE. Testicular and paratesticular tumors and tumor-like lesions of ovarian common epithelial and Mullerian types. Am J Clin Pathol 1986; 86: 146-52.
5. Elbadawi A, Batchvarov MM, Linke CA. Intratesticular papillary mucinous cystadenocarcinoma. Urology 1979; 14: 280-84.
6. Nistal M, Revestido R, Paniagua R. Bilateral mucinous cystadenocarcinoma of the testis and epididymis. Arch Pathol Lab Med 1992; 116: 1360-63.
7. Hsu SM, Raine L, Fangur H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparision between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 1981; 9: 577-80.
8. Rubin BP, Skarin AT, Pisick E et al. Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer. Eur J Cancer Prev 2001; 10: 77-82.
9. Dabbs DJ. Ovary, fallopian tube, and female pelvic peritoneum. In: Zorab R, ed. Diagnostic Immunohistochemistry. Philadelphia: Churchill Livingstone, 2002; 500-1.
10. Srigley JR, Mackay B, Toth P, Ayala A. The ultrastructure and histogenesis of male germ neoplasia with emphasis on seminoma with early carcinomatous features. Ultrastruc Pathol 1988; 12: 67-86.
11. Ulbright TM, Roth LM. Testicular and paratesticular neoplasms. In: Sternberg SS, ed. Diagnostic Surgical Pathology. New York: Raven Press, 1994; 885-947.
12. Tashiro Y, Yonezawa S, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrates and core protein in human ovarian tumors. Human Pathol 1994; 25: 364-72.
13. Reis CA, David L, Correa P et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999; 59: 1003-7.
14. Albarracin CT, Jafri J, Montag AG, Hart J, Kuan SF. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colon carcinoma: Hum Pathol 2000; 31: 672-7.
15. Park SY, Kim HS, Hong EK, Kim WH. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 2002; 33: 1078-85.
16. Loy TS, Galaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994; 102: 764-7.
17. Soong R, Robbins PD, Dix BR et al. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol 1996; 27: 1050-55.
18. Olshan AF, Weissler MC, Pei H et al. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene 1997; 14: 811-18.
19. Selvakumaran M, Lin HK, Miyashita T et al. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 1994; 9: 1791-8.
20. Heidenreich A, Schenkman NS, Sesterhenn IA et al. Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours. APMIS 1998; 106: 90-100.
21. Terlikowski S, Sulkowski S, Lenczewski A, Musiatowicz B, Kulikowski M. Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining. Arch Gynecol Obstet 1999; 263: 29-33.